Diatheva COVID-19 PCR kit is a CE-IVD, one-step multiplex RT-PCR assay and allows the qualitative detection of SARS-CoV-2-RNA in upper and lower respiratory samples during the acute phase of infection.
The kit is based on the use of labeled probes to confirm the presence of SARS-CoV-2 RNA by simultaneous amplification of targets ORF1b and N.
The assay also includes the RNase P target as an internal positive control (IC) to monitor that the sample is of acceptable quality, to monitor the RNA extraction process and the presence of PCR inhibitors.
Diatheva COVID-19 PCR Kit
Description
SARS-CoV-2 virus, a single-stranded RNA virus, is the cause of coronavirus 2019 respiratory disease (COVID-19) [WHO, March 2, 2020]. SARS-CoV-2 is contagious to humans and the World Health Organization (WHO) has designated the current COVID-19 pandemic as a Public Health Emergency of International Concern. PCR testing of asymptomatic or mildly symptomatic patients can be considered in the clinical evaluation of individuals who have come into contact with a COVID-19 case. The test is based on the guidelines issued by the WHO.
Additional information
Size | 96 tests |
---|---|
Application | Clinical diagnostics |
Product type | Diagnostic kit |
Reagent type | PCR |
Category | COVID-19 |
Technical information
Size | 96 tests |
---|---|
Technology | Real-time PCR |
Specimen | Upper and lower respiratory samples |
Target gene | SARS-CoV-2 ORF1b and N genes |